- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01268007
Heartbeat Sensitivity Calibration Using the ECG Accessory
This is an Observational, Un-blinded, Non-significant Risk, Non-interventional Study Designed to Collect ECG Data on at Least One Subject Out of a Pool of up to Three (3) Healthy Male Subjects at One Clinical Site (Clinical Trials of Texas).
Study Overview
Status
Conditions
Detailed Description
This is an observational, un-blinded, non-significant risk, non-interventional study designed to collect ECG data on at least one subject out of a pool of up to three (3) healthy male subjects at one clinical site (Clinical Trials of Texas). If acceptable data is acquired from one (1) subject the remaining subjects will not be entered into the study. Three (3) to six (6) researchers will record data, but all direct contact with the subject will be done by the study coordinator or principal investigator (PI).
The purpose of this study is to validate a Heartbeat Sensitivity calibration process utilizing the Cyberonics ECG Accessory. The non-invasive, passive collection of ECG signals from a resting healthy subject will be used to validate the use of the ECG Accessory with the Model 201 Programming Wand, Model 250 VNS Programming Software Version 9.0, Model 106 Generator, and ECG monitor (DRE True ECG-12), as well as the associated Instructions for Use. The data generated from this exercise will be used in future clinical trials utilizing this device.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Texas
-
San Antonio, Texas, United States, 78229
- Clinical Trials of Texas
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 1. Patients must be 18 years or older, male, and of any race.
- 2. Patient must be in good general health, fully ambulatory, and able to complete the physical aspects of testing requirements.
- 3. Patient must be willing and able to complete informed consent and HIPAA authorization.
Exclusion Criteria:
- 1. Subjects with skin abnormalities or conditions that would interfere with ECG electrode patch placement or cause subject discomfort with patch placement.
- 2. Subjects report history of allergies or sensitivity to adhesive tapes or patches.
- 3. Subjects with major health condition that in the investigator's judgment would prevent the subject's successful completion of the study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Normal ECG measurements
Observational, un-blinded, non-interventional study designed to collect ECG data on at least one (1) male patient in an outpatient setting.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of ECG measurements
Time Frame: 8 hours
|
No specific effectiveness outcomes or calculations are planned for this non-interventional study.
The sponsor will use the ECG data collected during this study as a comparison of the subject's actual ECG waveforms obtained through standard ECG connections to the ECG Accessory transmitted heart beat detection signals from the Model 106 Generator to the ECG monitor.
|
8 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- E-46
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ECG Comparisons in Normal Healthy Subject
-
Procter and GambleCompletedNormal Healthy Subject PopulationUnited States
-
Nervive, Inc.Centro Nacional de Investigacion en Imagenologia e Instrumentacion Medica...Completed
-
Isofol Medical ABCompletedPhase I Study in Healthy Volunteers to Evaluate ECG EffectSweden
-
Achaogen, Inc.Department of Health and Human ServicesCompletedA Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy VolunteersCardiac Effects in Normal Healthy VolunteersUnited States
-
University Hospital, Basel, SwitzerlandUniversity Children's Hospital BaselRecruitingNormal Values of Peripheral Nerves in Healthy ChildrenSwitzerland
-
Centre Mutualiste de Rééducation et de Réadaptation...CompletedHealthy Volunteers | Gait | Child Development | Normal Gait | Normal Gait in Children | Pediatric Normative Gait DataFrance
-
Monell Chemical Senses CenterHVMN (funding; holder of primary Department of Defense STTR contract)CompletedFlavor Perception in Normal, Healthy AdultsUnited States
-
Selcuk UniversityCompletedLiver Stiffness | Spleen Stiffness | Shear Wave Elastography in Healthy Children | Normal Organ Elasticity | Pediatric ElastographyTurkey (Türkiye)
-
Mastelli S.r.l1MedRecruitingSkin Elasticity | Skin Hydration in Healthy Volunteers | Aesthetic Improvement of the Skin | Skin Turgor | Subject SatisfactionItaly
-
Quaid-e-Azam UniversityCompletedKisspeptin Action on Insulin in Healthy Normal Men | Kisspeptin Action on Insulin in Obese Diabetic Men